Alzheimer’s Drug Fails in Late-Stage Trial Dashing Hopes

Nov 23, 2016, 09:40 by Michael Croft

STAT | An investigational Alzheimer's treatment from Eli Lilly failed to slow the progression of the memory-destroying disease in a late-stage trial.

November 23, 2016 | An investigational Alzheimer's treatment from Eli Lilly failed to slow the progression of the memory-destroying disease in a late-stage trial. STAT